Beverly A. Heinz - Concepedia

Author

Beverly A. Heinz

Eli Lilly (United States)

Also Known As

Beverly A Heinz, Beverly A. Heinz, Beverly Heinz, Heinz, Beverly A.

112

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Eli Lilly (United Kingdom)Eli Lilly (Spain)National Institutes of Health National Institute of Allergy and Infectious Diseases

About

Beverly A. Heinz is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	974
2	Natural Sciences	12	13	544
3	Biochemistry	12	13	489
4	Social Sciences	6	6	225
5	Allergy	2	2	98

Beverly A. Heinz

Publications

Citations

H-Index

Page 1

	Year	Citations
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett, Science Translational Medicine	2021	484
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang, Cell Reports	2022	452
2-Amino-3-substituted-6-[(<i>E</i>)-1-phenyl-2-(<i>N</i>-methylcarbamoyl)vinyl]imidazo[1,2-<i>a</i>]pyridines as a Novel Class of Inhibitors of Human Rhinovirus: Stereospecific Synthesis and Antiviral Activity Chafiq Hamdouchi, Jesús de Blas, Mirian del Prado, Journal of Medicinal Chemistry	1998	276
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett,	2020	173
Template Requirements for RNA Synthesis by a Recombinant Hepatitis C Virus RNA-Dependent RNA Polymerase C. Cheng Kao, Xueyong Yang, Allen D. Kline, Journal of Virology	2000	122
Targeting Group II Metabotropic Glutamate (mGlu) Receptors for the Treatment of Psychosis Associated with Alzheimer’s Disease: Selective Activation of mGlu2 Receptors Amplifies β-Amyloid Toxicity in Cultured Neurons, Whereas Dual Activation of mGlu2 and mGlu3 Receptors Is Neuroprotective Filippo Caraci, Gemma Molinaro, Giuseppe Battaglia, Molecular Pharmacology	2010	115
Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant α4β2 Nicotinic Acetylcholine Receptors Ruud Zwart, Anna L. Carbone, Mirko Moroni, Molecular Pharmacology	2008	108
N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes Matthew Fell, Jeffrey M. Witkin, Julie F. Falcone, Journal of Pharmacology and Experimental Therapeutics	2010	99
Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism Akihiko Kato, Kevin D. Burris, Kevin M. Gardinier, Nature Medicine Synaptic TransmissionNeurotransmitterNeuromodulation TherapiesSynaptic SignalingSocial Sciences	2016	88
Cytoskeletal Requirements for Hepatitis C Virus (HCV) RNA Synthesis in the HCV Replicon Cell Culture System Anne Gibson Bost, Daryl F. Venable, Lifei Liu, Journal of Virology Viral ReplicationCytoskeletal RequirementsHepatitis C VirusMolecular BiologyCytoskeleton	2003	74

Page 1